GlassScriptPhysician profile
Joel Page
NPI 1700347085
$805.24
in general payments reported to CMS, 2019-2025
11 companies · $15.63 in 2025
The $15.63 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $125 · 2020: $79.42 · 2021: $285 · 2022: $191 · 2023: $20.39 · 2024: $89.38 · 2025: $15.63.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $125.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $125.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $183.85 | 2022-2025 | |
| Eisai INC. | $140.18 | 2020-2021 | |
| Lundbeck LLC | $125.00 | 2019 | |
| Acorda Therapeutics, INC | $113.38 | 2021 | |
| Ucb, INC. | $89.38 | 2024 | Briviact |
| Emd Serono, INC. | $56.47 | 2020-2022 | |
| Acadia Pharmaceuticals INC | $35.70 | 2021 | |
| Alexion Pharmaceuticals, INC. | $23.27 | 2022 | |
| Upsher-Smith Laboratories LLC | $13.85 | 2021 | |
| Lilly USA, LLC | $12.57 | 2020 | |
| Chiesi USA, INC. | $11.59 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joel Page listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.